May 28, 2015

LRRK2 Promotes Tau Accumulation, Aggregation and Release

Molecular Neurobiology
Patrícia Silva GuerreiroKatrin Eckermann


Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are known as the most frequent cause of familial Parkinson's disease (PD), but are also present in sporadic cases. The G2019S-LRRK2 mutation is located in the kinase domain of the protein, and has consistently been reported to promote a gain of kinase function. Several proteins have been reported as LRRK2 substrates and/or interactors, suggesting possible pathways involved in neurodegeneration in PD. Hyperphosphorylated Tau protein accumulates in neurofibrillary tangles, a typical pathological hallmark in Alzheimer's disease and frontotemporal dementia. In addition, it is also frequently found in the brains of PD patients. Although LRRK2 is a kinase, it appears that a putative interaction with Tau is phosphorylation-independent. However, the underlying mechanisms and the cellular consequences of this interaction are still unclear. In this study, we demonstrate an interaction between LRRK2 and Tau and that LRRK2 promotes the accumulation of non-monomeric and high-molecular weight (HMW) Tau species independent of its kinase activity. Interestingly, we found that LRRK2 increases Tau secretion, possibly as a consequence of an impairment of Tau proteasomal degradation. Our d...Continue Reading

  • References49
  • Citations15


Mentioned in this Paper

Biochemical Pathway
Proteasome Pathway
HEK293 Cells
Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2
Protein Digestion
Neurofibrillary Degeneration (Morphologic Abnormality)

Related Feeds

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Alzheimer's Disease: Genes&Microglia

Genes and microglia are associated with the risk of developing and the progression of conditions such as Alzheimer's Disease (AD). Here are the latest discoveries pertaining to this disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Chiara CriscuoloGiuseppe De Michele
Annals of Neurology
Benoit I GiassonVivianna M Van Deerlin
Benoit I Giasson, Vivianna M Van Deerlin
Neuro-degenerative Diseases
Shamol SahaBenjamin Wolozin
© 2020 Meta ULC. All rights reserved